Loading the section…
Up to five U.S. securities side by side.
| Metric | HALOHalozyme Therapeutics, Inc. |
|---|---|
| Price | 130.92 |
| Change | −0.20 % |
| Return, 1 year | +75.27 % |
| Market capitalisation | 14.9B |
| Price / earnings | 36.1 |
| Price / sales | 9.0 |
| Price / book | 104 |
| Enterprise value / EBITDA | 27.6 |
| Return on equity | 288.13 % |
| Net margin | 24.86 % |
| Revenue, last year | 1.7B |
| Net income, last year | 414M |
| Revenue growth, year over year | +41.15 % |
| Debt / equity | 15.0 |
| Volatility, 30 days | 31.46 % |
| Beta | 0.49 |
| Sector | Health care |
Data: US exchange trading and company filings with the regulator